Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04905524 · ClinicalTrials.gov registry record · NA
Activity Changes in Irritable Bowel Syndrome (IBS), Anxiety, and Depression Following the Use of Viome Precision Nutrition Program (VPNP)
A NA study, sponsored by Viome.
- Completed
- Registry status
- NA
- Development phase
- 10,000
- Enrollment target
NCT04905524: Completed NA study, sponsored by Viome.
NCT04905524 is a NA study that has completed, run by Viome. The registered enrollment target is 10,000 participants, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (613% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04905524, a NA study, has completed, sponsored by Viome.
- COMPLETED
- Registry status
- NA
- Development phase
- 10,000 participants
- Enrollment target
Study Summary
Viome costumers are consented and recruited for this study and complete the questionnaires upon enrollment. Any participant who previously self reported depression, anxiety, or Irritable Bowel Syndrome (IBS) qualify for this study. All participants receive Viome's diet, supplement and recommendations.
Primary Outcome
Change of disease activity measurements in participants with self reported IBS after they have received Viome Precision Nutrition Program (VPNP), which consists of dietary supplement recommendations from Viome using clinically validated questionnaires. For IBS, Rome IV classification and criteria based on interpretation and self reporting of IBS, experience and symptoms were used to measure before and after VPNP for approximate duration of 5 months.
Interventions
- DIETARY_SUPPLEMENT VIOME Precision Nutrition Program
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10,000 participants |
| Start Date | 2020-09-01 |
| Est. Completion | 2022-03-23 |
| Phase | NA |
What the finished NCT04905524 record still lists
NCT04905524 is an interventional study that assigns participants to a tested intervention. Its 10,000 participants enrollment target places it among the larger protocols in the corpus, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (613% higher).
The record links to 0 conditions, and to 1 intervention - of which VIOME Precision Nutrition Program is the first listed.
NCT04905524 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04905524 about?
NCT04905524 is a clinical study titled "Activity Changes in Irritable Bowel Syndrome (IBS), Anxiety, and Depression Following the Use of Viome Precision Nutrition Program (VPNP)". Viome costumers are consented and recruited for this study and complete the questionnaires upon enrollment. Any participant who previously self reported depression, anxiety, or Irritable Bowel Syndrome (IBS) qualify for this study. All participants receive Viome's diet, supplement and recommendatio...
What is the current status of trial NCT04905524?
This trial is currently completed. It is a NA study. The enrollment target is 10,000 participants. The study started on 2020-09-01. Estimated completion is 2022-03-23.
What interventions are being tested in trial NCT04905524?
The interventions under investigation include: VIOME Precision Nutrition Program (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT04905524?
This trial is sponsored by Viome, which has 18 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04905524's enrollment target sits among peer trials
10,000 14th of 2000 higher than 1,985 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00160771 · 10,000 participants
Biomechanics/Motion Analysis Laboratory Data Bank
- NCT00896935 · 10,000 participants
Arizona Cancer Center Biospecimen Repository
- NCT00898235 · 10,000 participants
Collection of Samples and Clinical Data From Patients With Amyloid Diseases
- NCT00992303 · 10,000 participants
Collecting Tissue Samples From Patients With Cancer Undergoing Radiation Therapy and Healthy Participants
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI